Cite
In vivo flow cytometry reveals an anti‐metastatic effect of Rujifang in triple‐negative breast cancer.
MLA
Zhang, Fuli, et al. “In Vivo Flow Cytometry Reveals an Anti‐metastatic Effect of Rujifang in Triple‐negative Breast Cancer.” Cytometry. Part A, vol. 103, no. 9, Sept. 2023, pp. 723–31. EBSCOhost, https://doi.org/10.1002/cyto.a.24768.
APA
Zhang, F., Li, H., Lin, X., Zhu, X., Chen, X., Wang, B., Zhu, Z., Chen, X., Liang, G., Zhang, J., Wei, X., & Tian, H. (2023). In vivo flow cytometry reveals an anti‐metastatic effect of Rujifang in triple‐negative breast cancer. Cytometry. Part A, 103(9), 723–731. https://doi.org/10.1002/cyto.a.24768
Chicago
Zhang, Fuli, Hongliang Li, Xuan Lin, Xi Zhu, Xuezhang Chen, Bin Wang, Zhixia Zhu, et al. 2023. “In Vivo Flow Cytometry Reveals an Anti‐metastatic Effect of Rujifang in Triple‐negative Breast Cancer.” Cytometry. Part A 103 (9): 723–31. doi:10.1002/cyto.a.24768.